“Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c” (2003) Swiss Medical Weekly, 133(3334), pp. 455–460. doi:10.4414/smw.2003.10300.